Milestone Pharmaceuticals (MIST) Other financing activities (2018 - 2026)

Milestone Pharmaceuticals (MIST) has reported Other financing activities for 9 consecutive years, with $9.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other financing activities changed N/A year-over-year to $9.1 million; the trailing twelve-month figure through Jun 2026 stood at $17.7 million (up 8176.17% YoY), and the FY2025 full-year result was $444000.0, up 132.46% from the prior year.
• Other financing activities climbed to $9.1 million in Q2 2026 per MIST's latest filing, from $8.3 million in the prior quarter.
• Across five years, Other financing activities topped out at $9.1 million in Q2 2026 and bottomed at $19000.0 in Q2 2023.
• Historically, Other financing activities has averaged $1.3 million across 5 years, with a median of $140000.0 in 2022.
• The sharpest annual moves came in 2023 and 2026: Other financing activities sank 86.43% in 2023, then soared 5822.14% in 2026.
• Over 5 years, Other financing activities stood at $203000.0 in 2022, then grew by 20.69% to $245000.0 in 2023, then plunged by 69.8% to $74000.0 in 2024, then soared by 94.59% to $144000.0 in 2025, then jumped by 6230.56% to $9.1 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $9.1 million, $8.3 million, and $144000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.